Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Shire image

Shire signs antibody research deal with arGEN-X

February 29, 2012 Research and Development Shire, arGEN-X, monoclonal antibodies

Shire has signed a deal with antibody specialists arGEN-X to develop drugs for rare genetic diseases.Rotterdam-based arGEN-X will use its …
News

LEO Pharma appoints new executive vice president

February 29, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing LEO Pharma, supply chain

From March Anders Spohr will take over the position of executive vice president for global product supply at LEO Pharma. …
Appointment

NHS must adopt new technologies faster, says minister

February 28, 2012 Research and Development ABPI, NHS, Whitehead, Willetts, innovation

The NHS needs to speed up its adoption of new technology, according to universities and science minister David Willetts. Echoing …
News

ICON acquires market access consultancy

February 28, 2012 Research and Development CRO, ICON, pharma market access, pricing and reimbursement

ICON has acquired consulting firm PriceSpective, helping to expand the contract research organisation’s services in the field of pricing and …
News

On-going Medicine evaluation Information to be published by European Medicines Agency

February 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA), …
News
Press release

EMA accepts Genzyme MS drug for review

February 24, 2012 Research and Development, Sales and Marketing EMA, Genzyme, Sanofi, teriflunomide

The European Medicines Agency has accepted Genzyme’s application for its multiple sclerosis pill teriflunomide.  Genzyme, which is wholly owned by …
News
werner_wenning_bayer

Werner Wenning proposed as chairman of the supervisory board at Bayer

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Schneider, Wenning

Former Bayer chief executive Werner Wenning is set to be elected to the supervisory board at Bayer with effect from October. …
Appointment
Genzyme picture

Genzyme to close UK site

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, UK, job cuts

Genzyme will close its Cambridge R&D site by the end of the year, with a loss of around 60 jobs.  …
News

The NHS, a postcard from the frontline

February 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brighton, NHS, Sussex, reforms

It is January 2012, and the NHS in England is under huge strain. This is because it is being asked …
Feature

Astellas hires senior vice president for new Global Medical Affairs organisation

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing

Astellas has announced that Charlotte Kremer has joined the company as the head of one of the Company’s newest organisations …
Appointment

Alex Gorsky named new chief executive of J&J

February 22, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Janssen, Weldon

Johnson & Johnson has named Alex Gorsky as its new chief executive, effective from 26 April. Gorsky was also nominated …
Appointment
Takeda image

Takeda’s ulcerative colitis drug gets Phase III boost

February 22, 2012 Research and Development

Takeda’s ulcerative colitis drug vedolizumab has succeeded in a late-stage trial.  The Phase III trial studied vedolizumab in 895 patients …
News
Georg Toufar

Working Life: Georg Toufar, director, Mundipharma

February 21, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Georg Toufar, Mundipharma, Working Life

Georg Toufar is director of European marketing and sales and member of the executive committee at Mundipharma International Limited (MINT).  …
Feature

Bayer eye drug succeeds in long-term study

February 21, 2012 Research and Development, Sales and Marketing Bayer, Lucentis, aflibercept, wet AMD

Bayer’s eye drug aflibercept has succeeded in a long-term study in patients with a common eye condition.  The Phase III …
News

Contract research news in brief

February 21, 2012 Research and Development Almac, GVK Biosciences and PreClinOmics/AIT, PPD, Quintiles

Our round-up of news from the contract research sector includes PPD’s sales to a private equity consortium, new clinical supply …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026